bcbsm glp-1 coverage Announces Changes Amidst Trump Proposal | Dustin VanDuine, CLU posted on the topic Medicare covers GLP-1s for $50/month
Description
Although rare, associations with nonarteritic anterior ischemic optic neuropathy, pancreatitis, medullary thyroid carcinoma, and acute kidney injury (AKI) have been reported, primarily through pharmacovigilance and case-based evidence
The deal, which includes Eli Lilly and Novo Nordisk, will slash prices for Medicare and Medicaid programme recipients.
GLP-1 use is changing coffee habits, with consumers drinking less but more deliberately, focusing on ingredients, timing and functional value
Novo Nordisk India chief says GLP-1 adoption remains low and the market untapped despite patent expiry opening it to generics
for these drugs in 2023 (the latest year I found data for) was $71,700,000,000 (yes, 71.7 billion
The key takeaway
